SCHEMBL4196359

SCHEMBL4196359

NNC(=O)c1nccnc1NC(=O)c1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
KCNQ3 O43525 1/20 0.44
KCNQ2 O43526 1/20 0.44
KCNE1 P15382 1/20 0.44
KCNQ1 P51787 1/20 0.44
BACE1 P56817 1/20 0.44
PTPN1 P18031 2/20 0.44
TP53 P04637 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 2/20 0.43
P4HTM Q9NXG6 1/20 0.43
HDAC1 Q13547 1/20 0.43
MAPT P10636 2/20 0.43
MITF O75030 1/20 0.43
ALDH1A1 P00352 1/20 0.43
PPARG P37231 1/20 0.43
NCOA2 Q15596 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13951509 0.87 MEN1 (0.42) MEN1KMT2ACYP11B1CYP11B2KCNQ3
SCHEMBL3240438 0.81 NPC1 (0.56) MEN1KMT2ACYP11B1CYP11B2KCNQ3
SCHEMBL3232662 0.77 NPC1 (0.54) MEN1KMT2ATP53SMN1; SMN2MAPT
SCHEMBL9908251 0.75 MPO (0.64) MEN1KMT2APTPN1KDM4EHDAC1
SCHEMBL222973 0.75 MPO (0.64) MEN1KMT2APTPN1KDM4EHDAC1
SCHEMBL11840654 0.73 MEN1 (0.60) MEN1KMT2ACYP11B1CYP11B2KCNQ3
Hydrochloric Acid SCHEMBL5800195 0.73 MPO (0.61) MEN1KMT2APTPN1KDM4EHDAC1
Water SCHEMBL8856772 0.73 MPO (0.61) MEN1KMT2APTPN1KDM4EHDAC1
SCHEMBL26039099 0.73 PRKCI (0.48) MEN1KMT2AKDM4ERAB9A
SCHEMBL4249220 0.73 PTPN1 (0.73) MEN1KMT2AKCNQ3KCNQ2KCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-04-23 US disclosed
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-04-23 US disclosed
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-04-23 US disclosed
WO-2009026241-A1 HETEROCYCLIC MODULATORS OF TGR5 KALYPSYS, INC. (US) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105124-A1 HETEROCYCLIC MODULATORS OF TGR5 GPBAR1, GPR119, GRK5 MEN1 4670/4885KMT2A 4409/4885CYP11B1 2321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.